A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business We were founded in 1993 and in 2007 were reincorporated from a Massachusetts corporation to a Delaware corporation. We changed our name from CardioTech International, Inc. to AdvanSource Biomaterials Corporation, effective October 15, 2008. On March 3, 2020, we changed our name to EKIMAS Corporation. On October 12, 2021, we entered into a Stock Purchase Agreement (the “SPA”) with Reddington Partners LLC, a California limited liability company (“Reddington”) providing for the purchase of a total of 511,448 shares of our common stock, on a post-split basis, or approximately 90% of our total shares of common stock outstanding for total cash consideration of $400,000. Reddington purchased the common stock in two tranches on October 12, 2021 (the “First Closing”) and March 15, 2022. Pursuant to the SPA, the Company effectuated a 1-for 50 reverse stock split on March 11, 2022 (the “Reverse Split”).
| Metric | TTM | FY2025 | FY2024 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | 2.7M | - | - |
| Net Income | -4.6M | -2.9M | -298K | - | 334K | -202K |
| EPS | $-0.19 | $-0.32 | $-0.29 | - | $0.10 | $-0.10 |
| Free Cash Flow | 0 | -1.3M | -259K | - | -31K | 108K |
| ROIC | -5.0% | -4.8% | -17.0% | - | - | - |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.17 | - | - | - | - |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -4.1M | -2.9M | -308K | - | 751K | 181K |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -7.0% | -9.4% | - | - | - | - |
| Shares Outstanding | 19M | 9M | 17M | - | 3M | 2M |
Nordicus Partners Corp passes 0 of 9 quality checks, indicating weak fundamentals.
At current prices, the estimated annualized return to fair value is -17.6%.
Nordicus Partners Corp (NORD) has a 5-year average return on invested capital (ROIC) of -10.9%. This is below average and may indicate limited pricing power.
Nordicus Partners Corp (NORD) has a market capitalization of $77M. It is classified as a small-cap stock.
Nordicus Partners Corp (NORD) does not currently pay a regular dividend.
Nordicus Partners Corp (NORD) operates in the Services-Management Consulting Services industry, within the Industrials sector.
Nordicus Partners Corp (NORD) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Nordicus Partners Corp (NORD) has a debt-to-equity ratio of 0.17. This indicates a conservatively financed balance sheet.
Nordicus Partners Corp (NORD) reported earnings per share (EPS) of $-0.32 in its most recent fiscal year.
Nordicus Partners Corp (NORD) has a return on equity (ROE) of -9.4%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 12 years of financial data for Nordicus Partners Corp (NORD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Nordicus Partners Corp (NORD) has a book value per share of $6.60, based on its most recent annual SEC filing.
No recent press releases.